Theme: Exemplifying the Prominence of Enzymology among Interdisciplinary Sciences

Enzymology 2017
Past Report of Metabolomics Meeting 2016

Enzymology 2017

Conference Series LLC is delighted to invite all the participants across the globe to the prestigious event, International Conference on Enzymology which is going to be held during March 20-21, 2017 at Rome, Italy. This is an excellent opportunity for the delegates from Universities and Institutes to interact with the world class Scientists. The conference revolves around the theme – “Exemplifying the Prominence of Enzymology among Interdisciplinary Sciences”.

The broad subject coverage of the Conference and its size provide an excellent setting for participants to gain valuable insight into progress in research areas beyond their own. In addition, a range of special sessions aim to engage participants on wider issues, such as teaching in the enzymology research.

The Enzymology Conference has a strong emphasis on support and inspiration for the next generation of scientists, along with early-career researchers, a Young Researchers Forum, and activities to encourage interaction with peers and experts.

Altogether the conference aims to be an exemplary cross-discipline gathering in the proteomics life sciences for research presentation, discussion, learning, inspiration and encouragement with participants leaving with new research knowledge and ideas, and perhaps the beginnings of international collaborations and associations.

Track 1: Enzymology & Biochemistry

Biochemistry, sometimes called biological chemistry, is the study of chemical processes within and relating to living organisms. By controlling information flow through biochemical signalling and the flow of chemical energy through metabolism, biochemical processes give rise to the complexity of life. Over the last decades of the 20th century, biochemistry has become so successful at explaining living processes that now almost all areas of the life sciences from botany to medicine to genetics are engaged in biochemical research. Today, the main focus of pure biochemistry is on understanding how biological molecules give rise to the processes that occur within living cells, which in turn relates greatly to the study and understanding of tissues, organs, and whole organisms - that is, all of biology.

Relevant Conferences:

6th International Conference on Proteomics, March 29-31, 2016 Atlanta, USA; International Conference on Nucleic Acids: Biology, Human health and Diseases, August 04-05, 2016 New Orleans, Louisiana, USA; 2nd Genetic and Protein Engineering Conference, November 14-16, 2016 Atlanta, USA;  International Conference on Amino Acids & Proteins, December 08-09, 2016 Dallas Texas, USA; 6thInternational Conference on Metabolomics, November 14-16, 2016 Florida, USA; ICBB 2016 International Conference on Bioscience, Biotechnology, & Biochemistry, August 04-05 2016 Amsterdam, The Netherlands ; 2nd Conference on Advances in Biochemistry & Molecular Biology (CABMB 2016)   March 18-20, 2016 Los Angeles, USA; ICBMB 2016 - International Conference on Biochemistry & Molecular Biology, April 27-29 2016, Venice Italy; ICBBB 2016: 14th Asia-Pacific Federation for Clinical Biochemistry & Laboratory Medicine Conference, November 26-29 2016, Taipei.

Track 2: Structural Enzymology

Enzymes are proteins processing cellular metabolism. They can affect a reaction by catalysing and they can be used to reverse the reaction in bio-chemical pathways. Though enzymes have complex enzyme structure they undergo many changes which is very important for reactions and so enzyme structure is very important. There is a specific enzyme for specific reaction.

Enzymes structures are made up of α amino acids which are linked together via amide (peptide) bonds in a linear chain. This is the primary structure. The resulting amino acid chain is called a polypeptide or protein. The specific order of amino acids in the protein is encoded by the DNA sequence of the corresponding gene.

Relevant Conferences:

5th International Conference on Computational Systems Biology August 22-23, 2016 Philadelphia, USA; International Conference on Structural Biology August 22-23, 2016 New Orleans, Louisiana, USA; 6thInternational Conference on Bioinformatics & Computational Systems Biology August 22-23, 2016 Philadelphia, Pennsylvania, USA; International Conference on Next Generation Sequencing November 17-18, 2016 Atlanta, USA; 7th International Conference on Bioinformatics October 24-25, 2016 Rome, Italy; Molecular Medicine Tri-Conference 2016, March 06-11 2016, San Francisco, USA; G Protein-Coupled Receptors: Structure, Signaling & Drug Discovery February 21-25, 2016 Colorado, USA; ICMBBB 2016: 18th InternationalConference on Molecular Biology, Biochemistry & Biotechnology, January 28-29 2016, Dubai UAE; PROTSTAB2016 - 11thInternational Conference on Protein Stabilization, May 09-11 2016, Istanbul Turkey; Structure Based Drug Design Conference 2016, February 21-24 2016, San Diego, USA.

Track 3: Molecular Enzymology

Molecular enzymology is designing and synthesis of enzymes and high unmet medical needs are based on innovative drug targets. The work of designing and synthesis of enzymes and high unmet medical need are based on innovative drug targets.

Molecular Enzymology's interest include in all aspects related to enzymes like discovery of enzymes, enzyme structure, enzyme mechanisms, cellular and metabolic functions of enzymes, exploitation of enzymes for biotechnological and pharmaceutical applications, drug discovery, biochemical aspects of enzymes, bioinformatics, computational analysis, molecular modelling studies, new methods in enzyme expression and purification, bio catalysis, bio molecular engineering, enzyme kinetics and inhibitors.

Relevant Conferences:

7th International Conference on Proteomics, October 24-26, 2016 Rome, Italy; 2nd International Conference on Genetic  &  Protein Engineering, November 14-16, 2016 Atlanta, USA; 2nd International Conference on Lipid Science & Technology, October 03-05, 2016 Orlando, USA; International Conference on Amino Acids and Proteins, December 08-09, 2016 Dallas Texas, USA; International Conference on Molecular & Cancer Biomarkers, September 15-17, 2016 Berlin, Germany; Systems Immunology: From Molecular Networks to Human Biology, January 10-14, 2016 Montana, USA; ICBMB 2016 - International Conference on Biochemistry and Molecular Biology, April 27-29 2016 Venice, Italy; Molecular Medicine Tri-Conference 2016, March 06-11 2016 San Francisco, USA; Oligo 2016, April 06 2016, Oxford UK; Molecular Diagnostics World Summit 2016, May 19-20 2016, London UK.

Track 4: Enzymology in Drug Discovery

Enzymes are the proteins in the drug design that act as drug targets for the diseases in the process of drug discovery and development. There are number of drug targets involved in the designing of the drug.

Drug target is a nucleic acid or a protein (e.g. an enzyme, a receptor) whose activity can be modified by a drug. The drug can be a small-molecular-weight chemical compound or a biological, such as an antibody or a recombinant protein. The drug target should have been shown to be effective/mechanistically involved in the disease by relevant in vitro or in vivo models.

Relevant Conferences:

Seventh International Conference on Biomarkers & Clinical Research analysis, November 28-30, 2016, Baltimore, USA; Sixth International Conference & Expo exhibition on proteomics March 29-30, 2016, Atlanta, USA; Fifth  International Conference on Medicinal Chemistry Computer aided  Drug Designing December 01-03, 2016 Chicago, USA; Second International Conference and Exhibition on Molecular Medicine  and Diagnostics Sept 26-28, 2016 Miami, USA; Precision Medicine, March 7 – 9 2016,San Francisco, CA; The personalized medicine World Conference (PMWC) 2016, San Francisco, USA; Seventeenth International Meeting: Cell & Molecular biology Of Chlamydomonas, June 26 - July 1 2016, Kyoto, Japan; 18th International Conference on Genetic science and Molecular biology, Oct 10 - 11 2016, Osaka, Japan; 13th International Congress of Human Genetic science, April 3-7 2016, Kyoto, Japan.

Track 5: Enzymes & Metabolic Pathways

Metabolic pathway includes series of reactions in a cell for being of organism. It is of two types like catabolism and anabolism. Catabolism breaks the molecules and produces energy. Anabolism requires energy to break the molecules.

A metabolic pathway is a step-by-step series of interconnected biochemical reactions that convert a substrate molecule or molecules through a series of metabolic intermediates, eventually yielding a final product or products. For example, one metabolic pathway for carbohydrates breaks large molecules down into glucose. Another metabolic pathway might build glucose into large carbohydrate molecules for storage.

Relevant Conferences:

5th International Conference on Translational Medicine, November 17-19, 2016 San Francisco, USA; 2nd International Conference on Transcriptomics, August 18-20, 2016 Portland, Oregon USA; 5th International Conference on Computational Systems Biology , August 22-23, 2016 Philadelphia, USA ; International Conference on Clinical and Molecular Genetics, November 28-30, 2016, Chicago, USA; 2nd International Conference and Exhibition on Molecular Medicine and Diagnostics, September 26-28, 2016 Miami, USA; The Personalized Medicine World Conference (PMWC) 2016, San Francisco, USA; 17th International Meeting: Cell & Molecular Biology Of Chlamydomonas, June 26 - July 1 2016, Kyoto, Japan; 18th International Conference on Genetics and Molecular Biology, October 10 - 11 2016, Osaka, Japan; 13th International Congress of Human Genetics, April 3-7 2016, Kyoto, Japan.

Track 6: Cancer Enzymology

Cancer drug targets are the drugs that target cancer causing cells by preventing the cells to grow and develop. Many new anti- neoplastic agents are developed in the process of targeting malignant cells in the body.

Drug target is a nucleic acid or a protein (e.g. an enzyme, a receptor) whose activity can be modified by a drug. The drug can be a small-molecular-weight chemical compound or a biological, such as an antibody or a recombinant protein.

The drug target should have been shown to be effective/mechanistically involved in the disease by relevant in vitro or in vivo models. Cancer drug targets alter the metabolism of cancer causing cells by inhibiting the spread of the disease.

Relevant Conferences:

14th World Congress on Cancer Therapy December 05-07, 2016 Philadelphia, Pennsylvania, USA; 7th International Conference on Proteomics October 24-26, 2016 Rome, Italy; 2nd International Conference on Genetic and Protein Engineering November 14-16, 2016 Atlanta, Georgia, USA; International Conference on Amino Acids and Proteins December 08-09, 2016 Dallas, Texas, USA; 7thInternational Conference on Metabolomics November 14-16, 2016 Orlando, Florida, USA; 8th International Conference on Proteomics March 20-22, 2017 Philadelphia, Pennsylvania, USA; XI National Conference of the Italian Proteomic Association May 16-19, 2016 Perugia, Italy; HUPO 15th Annual World Congress September 18-22, 2016 Taipei, Taiwan; X Annual Congress of the European June 21-25, 2016 Istanbul, Turkey; US HUPO 12th Annual Conference March 13-16, 2016 Boston, Massachusetts; HUPO 16th Annual World Congress September 17-20, 2017 Dublin, Ireland.

Track 7: Computational Enzymology

Molecular simulations and modelling are changing the science of enzymology. Calculations can provide detailed, atomic-level insight into the fundamental mechanisms of biological catalysts. Computational enzymology is a rapidly developing area, and is testing theories of catalysis, challenging 'textbook' mechanisms, and identifying novel catalytic mechanisms. Increasingly, modelling is contributing directly to experimental studies of enzyme-catalysed reactions. Potential practical applications include interpretation of experimental data, catalyst design and drug development.

Relevant Conferences:

5th International Conference on Computational Systems Biology , August 22-23, 2016 Philadelphia, USA. 5th International Conference on Translational Medicine, November 17-19, 2016 San Francisco, USA; 2nd International Conference on Transcriptomics, August 18-20, 2016 Portland, Oregon USA; International Conference on Clinical and Molecular Genetics, November 28-30, 2016, Chicago, USA; 2nd International Conference and Exhibition on Molecular Medicine and Diagnostics, September 26-28, 2016 Miami, USA; The Personalized Medicine World Conference (PMWC) 2016, San Francisco, USA; 17th International Meeting: Cell & Molecular Biology Of Chlamydomonas, June 26 - July 1 2016, Kyoto, Japan; 18th International Conference on Genetics and Molecular Biology, October 10 - 11 2016, Osaka, Japan; 13th International Congress of Human Genetics, April 3-7 2016, Kyoto, Japan.

Track 8: Enzymology & Its Kinetics

Enzyme kinetics is the study of the chemical reactions that are catalysed by enzymes. In enzyme kinetics, the reaction rate is measured and the effects of varying the conditions of the reaction are investigated. Studying an enzyme's kinetics in this way can reveal the catalytic mechanism of this enzyme, its role in metabolism, how its activity is controlled, and how a drug or an agonist might inhibit the enzyme.

Relevant Conferences:

7th International Conference on Analytical and Bioanalytical Techniques September 28-30, 2016 Orlando, Florida, USA; 2ndInternational Conference on Current Trends in Mass Spectrometry July 20-22, 2016 Chicago, USA; World Congress on Chromatography September 21-23, 2016 Amsterdam, Netherlands; 7th International Conference on Proteomics October 24-26, 2016 Rome, Italy; 2nd International Conference on Genetic and Protein Engineering November 14-16, 2016 Atlanta, Georgia, USA; XI National Conference of the Italian Proteomic Association May 16-19, 2016 Perugia, Italy; HUPO 15th Annual World Congress September 18-22, 2016 Taipei, Taiwan; X Annual Congress of the European Proteomics Association June 21-25, 2016 Istanbul, Turkey; US HUPO 12th Annual Conference March 13-16, 2016 Boston, Massachusetts; HUPO 16th Annual World Congress September 17-20, 2017 Dublin, Ireland.

Track 9: Enzymology & Proteomics

Proteomics is the large-scale study of proteins, particularly their structures and functions. Proteins are vital parts of living organisms, as they are the main components of the physiological metabolic pathways of cells. The term proteomics was first coined in 1997 to make an analogy with genomics, the study of the genome. The word proteome is a portmanteau of protein and genome. The proteome is the entire set of proteins, produced or modified by an organism or system.

Relevant Conferences:

7th International Conference on Proteomics October 24-26, 2016 Rome, Italy; 2nd International Conference on Genetic and Protein Engineering November 14-16, 2016 Atlanta, Georgia, USA; International Conference on Amino Acids and Proteins December 08-09, 2016 Dallas, Texas, USA; 7th International Conference on Metabolomics November 14-16, 2016 Orlando, Florida, USA; 8thInternational Conference on Proteomics March 20-22, 2017 Philadelphia, Pennsylvania, USA; XI National Conference of the Italian Proteomic Association May 16-19, 2016 Perugia, Italy; HUPO 15th Annual World Congress September 18-22, 2016 Taipei, Taiwan; X Annual Congress of the European Proteomics Association June 21-25, 2016 Istanbul, Turkey; US HUPO 12th Annual Conference March 13-16, 2016 Boston, Massachusetts; HUPO 16th Annual World Congress September 17-20, 2017 Dublin, Ireland.

Track 10: Industrial Applications of Enzymology

Enzymes are used in the chemical industry and other industrial applications when extremely specific catalysts are required. Enzymes in general are limited in the number of reactions they have evolved to catalyse and also by their lack of stability in organic solvents and at high temperatures. As a consequence, protein engineering is an active area of research and involves attempts to create new enzymes with novel properties, either through rational design or in vitro evolution. These efforts have begun to be successful, and a few enzymes have now been designed "from scratch" to catalyse reactions that do not occur in nature.

Enzymes are usually protein molecules that manipulate other molecules — the enzymes substrates. These target molecules bind to an enzyme's active site and are transformed into products through a series of steps known as the enzymatic mechanism.

Relevant Conferences:

7th International Conference on Proteomics October 24-26, 2016 Rome, Italy; 2nd International Conference on Genetic and Protein Engineering November 14-16, 2016 Atlanta, Georgia, USA; International Conference on Amino Acids and Proteins December 08-09, 2016 Dallas, Texas, USA; 7th International Conference on Metabolomics November 14-16, 2016 Orlando, Florida, USA; 8thInternational Conference on Proteomics March 20-22, 2017 Philadelphia, Pennsylvania, USA; XI National Conference of the Italian Proteomic Association May 16-19, 2016 Perugia, Italy; HUPO 15th Annual World Congress September 18-22, 2016 Taipei, Taiwan; X Annual Congress of the European Proteomics Association June 21-25, 2016 Istanbul, Turkey; US HUPO 12th Annual Conference March 13-16, 2016 Boston, Massachusetts; HUPO 16th Annual World Congress September 17-20, 2017 Dublin, Ireland.

Track 11: Enzymology & Thermodynamics

In the presence of an enzyme, the reaction runs in the same direction as it would without the enzyme, just more quickly. For example, in carbonic anhydrase catalyses its reaction is either direction depending on the concentration of its reactants. The rate of a reaction is dependent on the activation energy needed to form the transition state which then decays into products. Enzymes increase reaction rates by lowering the energy of the transition state. First, binding forms a low energy enzyme-substrate complex (ES). Secondly the enzyme stabilises the transition state such that it requires less energy to achieve compared to the un catalyzed reaction (ES‡). Finally the enzyme-product complex (EP) dissociates to release the products.

Relevant Conferences:

International Conference on Anatomy & Physiology August 11-13, 2016 Birmingham, UK; 4th InternationalConference on Pharmacognosy, Phytochemistry & Natural Products August 29-31, 2016 Sao Paulo, Brazil; 2nd International Conference on Lipid Science & Technology October 03-05, 2016 Orlando, USA; 6th International Conference on Metabolomics November 14-16, 2016 Florida, USA; 4thInternational Conference on Integrative Biology July 18-20, 2016 Berlin, Germany; Euro Fed Lipid Conference 2016, September 18-21 2016, Gent Belgium; Southern California Bioenergetic Conference, February 18-21 2016, California USA; ICBMB 2016 - International Conference on Biochemistry and Molecular Biology, April 27-29 2016, Venice Italy; PROTSTAB2016 - 11th International Conference on Protein stabilization, May 09-11 2016, Istanbul Turkey; ICBBB 2016: 6th International Conference on Bioscience, Biochemistry & Bioinformatics, January 23-25 2016, Pattaya Thailand.

Track 12: Clinical Enzymology

Enzymes are catalysts that increase the rate or velocity of physiologic reactions. Each and every reaction in our body takes place with the help of an enzyme. In general, most enzymes are present in cells at much higher concentrations than in plasma. Measurement of their levels in plasma indicates whether their tissue of origin is damaged leading to the release of intracellular components into the blood. This forms the basis of clinical enzymology. Thus clinical enzymology refers to measurement of enzyme activity for the diagnosis and treatment of diseases.

Relevant Conferences:

International Conference on Molecular & Cancer Biomarkers, September 15-17, 2016 Berlin, Germany; 6th International Conference on Proteomics, March 29-30, 2016 Atlanta, USA; International Conference on Nucleic Acids: Biology, Human health and Diseases, August 04-05, 2016 New Orleans, Louisiana, USA; 2nd International Conference on Transcriptomics, September 12-14, 2016 Philadelphia, USA; 2nd InternationalConference on Genetic and Protein Engineering, November 14-16, 2016 Atlanta, Georgia, USA; The OxfordChemical Immunology Conference, April 04-05 2016, Oxford UK; Molecular Medicine Tri-Conference 2016, March 06-11 March 2016,     San Francisco, USA; Molecular Diagnostics  World Summit 2016, May 19-20 2016, London, UK; Noncoding RNAs in Health and Disease, February 21-24 2016, Santa Fe, USA; ICMBBB 2016 : 18th International Conference on Molecular Biology, Biochemistry and Biotechnology, January 28-29 2016, Dubai UAE.

Track 13: Biomass & Biofuel Resources

Biomass is organic matter derived from living, or recently living organisms. Biomass can be used as a source of energy and it most often refers to plants or plant-based materials which are not used for food or feed, and are specifically called lignocellulosic biomass. As an energy source, biomass can either be used directly via combustion to produce heat, or indirectly after converting it to various forms of biofuel. Conversion of biomass to biofuel can be achieved by different methods which are broadly classified into: thermal, chemical, and biochemical methods.

A biofuel is a fuel that is produced through contemporary biological processes, such as agriculture and anaerobic digestion, rather than a fuel produced by geological processes such as those involved in the formation of fossil fuels, such as coal and petroleum, from prehistoric biological matter. Biofuels can be derived directly from plants, or indirectly from agricultural, commercial, domestic, and/or industrial wastes. Renewable biofuels generally involve contemporary carbon fixation, such as those that occur in plants or microalgae through the process of photosynthesis. This biomass can be converted to convenient energy-containing substances in three different ways: thermal conversion, chemical conversion, and biochemical conversion. This biomass conversion can result in fuel in solid, liquid, or gas form. This new biomass can also be used directly for biofuels.

Relevant Conferences:

7th International Conference on Proteomics October 24-26, 2016 Rome, Italy; 2nd International Conference on Genetic and Protein Engineering November 14-16, 2016 Atlanta, Georgia, USA; International Conference on Amino Acids and Proteins December 08-09, 2016 Dallas, Texas, USA; 7th International Conference on Metabolomics November 14-16, 2016 Orlando, Florida, USA; 8thInternational Conference on Proteomics March 20-22, 2017 Philadelphia, Pennsylvania, USA; XI National Conference of the Italian Proteomic Association May 16-19, 2016 Perugia, Italy; HUPO 15th Annual World Congress September 18-22, 2016 Taipei, Taiwan; X Annual Congress of the European Proteomics Association June 21-25, 2016 Istanbul, Turkey; US HUPO 12th Annual Conference March 13-16, 2016 Boston, Massachusetts; HUPO 16th Annual World Congress September 17-20, 2017 Dublin, Ireland.

Track 14: Industrial fermentation processes for enzymes

Industrial fermentation is the intentional use of fermentation by microorganisms such as bacteria and fungi to make products useful to humans. Fermented products have applications as food as well as in general industry. Some commodity chemicals, such as acetic acid, citric acid, and ethanol are made by fermentation. The rate of fermentation depends on the concentration of microorganisms, cells, cellular components, and enzymes as well as temperature, pH and for aerobic fermentation oxygen. Product recovery frequently involves the concentration of the dilute solution. Nearly all commercially produced enzymes, such as lipase, invertase and rennet, are made by fermentation with genetically modified microbes. In some cases, production of biomass itself is the objective, as in the case of baker's yeast and lactic acid bacteria starter cultures for cheese making. In general, fermentations can be divided into four types:

  • Production of biomass (viable cellular material)
  • Production of extracellular metabolites (chemical compounds)
  • Production of intracellular components (enzymes and other proteins)
  • Transformation of substrate (in which the transformed substrate is itself the product)
  • Product Recovery
  • Production of Biomass
  • Production of Extracellular Metabolites
  • Production of intracellular Components
  • Transformation of Substrate

Relevant Conferences:

International Conference on Anatomy & Physiology August 11-13, 2016 Birmingham, UK; 4th InternationalConference on Pharmacognosy, Phytochemistry & Natural Products August 29-31, 2016 Sao Paulo, Brazil; 2nd International Conference on Lipid Science & Technology October 03-05, 2016 Orlando, USA; 6th International Conference on Metabolomics November 14-16, 2016 Florida, USA; 4thInternational Conference on Integrative Biology July 18-20, 2016 Berlin, Germany; Euro Fed Lipid Conference 2016, September 18-21 2016, Gent Belgium; Southern California Bioenergetic Conference, February 18-21 2016, California USA; ICBMB 2016 - International Conference on Biochemistry and Molecular Biology, April 27-29 2016, Venice Italy; PROTSTAB2016 - 11th International Conference on Protein stabilization, May 09-11 2016, Istanbul Turkey; ICBBB 2016: 6th International Conference on Bioscience, Biochemistry & Bioinformatics, January 23-25 2016, Pattaya Thailand.

Track 15: Enzymology Case Study

A case study is generally a documented study of a specific real-life situation or imagined scenario, used as a training tool in business schools and firms. Students or trainees are required to analyse the prescribed cases and present their interpretations or solutions, supported by the line of reasoning employed and assumptions made. The case study consists of various notes that represent the particular patient. The detail of the particular patient such as laboratory findings, Medical history, Family history, Social history, Physical examination, Treatment plan etc.

Relevant Conferences:

3rd Euro-Global Experts Meeting on Medical Case Reports June 30-July 02, 2016 Valencia, Spain; 7th International Conference on Proteomics October 24-26, 2016 Rome, Italy; 2nd International Conference on Genetic and Protein Engineering November 14-16, 2016 Atlanta, Georgia, USA; International Conference on Amino Acids and Proteins December 08-09, 2016 Dallas, Texas, USA; 7thInternational Conference on Metabolomics November 14-16, 2016 Orlando, Florida, USA; 8th International Conference on Proteomics March 20-22, 2017 Philadelphia, Pennsylvania, USA; XI National Conference of the Italian Proteomic Association May 16-19, 2016 Perugia, Italy; HUPO 15th Annual World Congress September 18-22, 2016 Taipei, Taiwan; X Annual Congress of theEuropean Proteomics Association June 21-25, 2016 Istanbul, Turkey; US HUPO 12th Annual Conference March 13-16, 2016 Boston, Massachusetts; HUPO 16th Annual World Congress September 17-20, 2017 Dublin, Ireland.

 

 

 

 

SUMMARY

Enzymology involves the study of enzymes and their structures. The reports in this section analyse the global enzymology market by application, equipment, tools, methodologies, software, and services. The applications segment for instance covers the markets for enzymology-based diagnosis and therapy; while the equipment segment covers markets for technologies such as microarrays, Ultrasonic processing, and Gel electrophoresis. Drug discovery forms the highest revenue-generating application market of enzymology. The reports give us the latest and forecasted revenues of all these market segments; and also provide us the exhaustive analyses of current trends, market, growth strategies, and opportunities that are adopted by the key market players.

IMPORTANCE & SCOPE:

Enzymology is the recent technology growing rapidly due to its higher application in a lot of fields and due to having bright and clear future vision. A most exciting development over the last few years is the application of genetic engineering techniques to enzymology. There are a number of properties which may be improved or altered by genetic engineering including the yield and kinetics of the enzyme, the ease of downstream processing and various safety aspects. Enzymes from dangerous or unapproved microorganisms and from slow-growing or limited plant or animal tissue may be cloned into safe high-production microorganisms. New enzyme structures may be designed and produced in order to improve on existing enzymes or create new activities.  A number of possibilities now exist for the construction of artificial enzymes. These are generally synthetic polymers or oligomers with enzyme-like activities, often called synzymes. Enzymes can be immobilized i.e., an enzyme can be linked to an inert support material without loss of activity which facilitates reuse and recycling of the enzyme. Use of engineered enzyme to form biosensor for the analytical use is also recent activity among the developed countries. Some enzymes make use in diseases diagnosis so they can be genetically engineered to make the task easier. Thus it is obvious that there is huge scope of the enzyme technology in the future as well as in present.

Why ROME, ITALY ?

Rome is the capital of Italy and the biggest city in Italy. It's additionally home of the Vatican City State. Rome is a clamouring city that offers understudies a huge abundance of history, society and worldwide impact readily available. With its numerous areas and sprawling verifiable locales, Rome gives you the feeling of being in a residential community, notwithstanding the actuality of being home to right around 3 million individuals.

GLOBAL LIFE SCIENCE MARKET SHARE BY COUNTRY:

 

Why to ATTEND???

Meet Your Target Market with recent business reports on Enzymology making news which manifests the tremendous growth in market value for enzymology technology till 2019. Since enzymology interrelated with omics sciences like Genomics, precision Medicine, Proteomics, Lipidomics, Fluxomics and Transcriptomics, it would be a great opportunity for companies dealing with Analytical instruments useful in these fields. Also many upcoming students and researchers can benefit themselves by participating world class International workshops, symposia during the conference which will be conducted by experts in the respective fields.

List of major ENZYMOLOGY RELATED SOCIETIES:

  • American Society for Biochemistry and Molecular Biology (ASBMB)
  • Association for Clinical Biochemistry (ACB)
  • Society for Integrative and Comparative Biology (SICB)
  • Canadian Society of Clinical Chemists (CSCC)
  • Society of Medical Biochemists of Serbia
  • Federation of European Biochemical Societies (FEBS)
  • American Chemical Society (ACS)
  • Clinical Laboratory and Analytical Sciences (CLAS)
  • Biochemical Society
  • Signal Transduction Society
  • International Conference on the Bioscience of Lipids
  • Society for Free Radical Research European Region (SFRR-Europe)
  • Canadian Society for Chemistry (CSC)
  • International Union of Pure and Applied Chemistry (IUPAC)
  • American Association for Clinical Chemistry (AACC)
  • European Federation of Clinical Chemistry and Laboratory Medicine (EFCCLM)
  • International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)
  • Royal Society of Chemistry (RSC)
  • Society for the Study of Inborn Errors of Metabolism (SSIEM)
  • Société de Chimie Thérapeutique (SCT)
  • International Society for Oncology and BioMarkers (ISOBM)
  • Federation of the American Societies for Experimental Biology (FASEB)
  • International Society for Antiviral Research (ISAR)
  • Cell Stress Society International (CSSI)
  • Drug, Chemical & Associated Technologies Association (DCAT)
  • American Institute of Chemical Engineers (AIChE)
  • German Chemical Society E. V.
  • European Society of Gene and Cell Therapy (ESGCT)
  • Japan Society of Gene Therapy (JSGT)
  • Korean Society of Gene and Cell Therapy (KSGT)
  • European Tissue Repair Society (ETRS)

TARGET AUDIENCE: 

Directors/Managers & Business Delegates,  Director of Laboratories, Universities, Industries, Investigators, Post-Doctoral Fellows, Research and Diagnostic Laboratories, Clinical Fellows, Students, Biomedical Research companies.  

Rise in the number of clinical trials, toxicological studies, and health awareness for nutritional products, rapid growth of enzymology data analysis software and solutions, and use of enzymology as diagnostics tool for biomarker screening of diseases is expected to propel the growth of this market. 

GLANCE AT MARKET OF ENZYMOLOGY:

The market for food enzymes is projected to reach USD 2.94 Billion by 2021, at a CAGR of about 7.4% from 2016. This market is fuelled by the growing awareness among consumers toward the health and nutritional benefits of food enzymes and the growth of end-use applications of food enzymes in the food and beverage industry.

The technical enzymes market is projected to reach USD 1.27 Billion by 2021, at a CAGR of 3.4% from 2016 to 2021. The technical enzymes market is also segmented on the basis of region into North America, Europe, Asia-Pacific, and the Rest of the World (RoW).

The key players in the market are BASF SE (Germany), E.I. du Pont de Nemours and Company (U.S.), Associated British Foods plc (U.K.), Koninklijke DSM N.V (The Netherlands), and Novozymes A/S (Germany) among others. The industrial enzymes market was valued at USD 4.2 Billion in 2014 and is projected to grow at a CAGR of 7.0% from 2015 to 2020. In 2014, the market was dominated by North America. The Asia-Pacific region is projected to grow at the highest CAGR from 2015 to 2020.

STATISTICS SHOWING GROWTH IN IMPORTANCE OF ENZYMOLOGY:

Enzymology Market Worth $4,100 Million by 2024 - New Report by Markets and Markets.

STATISTICS OF INDUSTRIES ASSOCIATED WITH ENZYMOLOGY:

The global enzymes market size was USD 8.18 billion in 2015 and is expected to witness significant growth over the next eight years on account of its increasing application in detergents, pharmaceuticals, and food & beverages.

Enzymes market is projected to show high gains in light of its extensive usage in food processing, germination in breweries, pre-digestion of baby food, fruit juice clarification, meat tenderization, cheese manufacturing, and conversion of starch into glucose. Also, favourable government policies by the U.S., Austria, France, Germany, Italy and Sweden to promote biodiesel production will fuel demand over the next eight years.

Growing product demand in various applications including paper, biofuels, rubber, photography, biological detergents, contact lens cleaners and molecular biology will promote industry expansion over the next eight years.

Increasing consumer awareness regarding the improved quality of food coupled with high population base and their dietary requirements is expected to create immense market potential over the next few years. Growing forensic and molecular biological research in the U.S. is projected to fuel the product demand over the next eight years.

SCOPE OF THE STUDY

The scope of enzymology has expanded rapidly over the last century, from an early focus on the chemical and catalytic mechanisms of individual enzymes to more recent efforts to understand enzyme action in the context of dynamic, functional biological systems consisting of many interacting enzymes and proteins. Continuing progress in probing the link between molecular structure and function now promises to pave the way for a deeper understanding of the evolution and behaviour of the complex biological systems that govern cellular behaviour.

Remarkable progress in chemistry and biology over the last century has provided deep insights into two fundamental questions: how do molecular components give rise to functioning biological systems, and how do complex biological systems evolve? We now have, in mechanistic detail, a considerable understanding of how biological macromolecules control growth, metabolism, signalling and other biological processes at the level of individual components, while sequence and structural comparisons have revealed the molecular-level changes that distinguish evolutionarily related macromolecules.

 

Conference Series LLC is delighted to invite all the participants across the globe to the prestigious event, International Conference on Enzymology which is going to be held during March 20-21, 2017 at Rome, Italy. Enzymology 2017 comes to grip with the sessions Enzymology & Biochemistry, Structural Enzymology, Molecular Enzymology, Enzymology in Drug Discovery, Enzymes & Metabolic Pathways, Cancer Enzymology, Computational Enzymology, Enzymology & Its Kinetics, Enzymology & Proteomics, Industrial Applications of Enzymology, Enzymology & Thermodynamics, Clinical Enzymology and Enzymology Case Study.

Conference Series LLC coordinates 1000+ Global events every year across USA,  Asia & Europe with support from more than 1000 scientific societies and publishes more than 700 Open access journals which involves over 100,000 eminent personalities, distinguished scientists as editorial board and organizing committee members. Conference Series LLC is authorized by International Congress and Convention Association. World Congress & International conference as momentously captivated by Nobel Laureate, International Symposiums and Workshops, Exhibitions, Keynote gatherings and Delegates.

For more conferences from Conference Series, Kindly go through conference series web page.

 

Welcome Message from Dr. Amnon Kohen

Welcome message for the participants of the International Conference on Enzymology:

It is my honor and pleasure to welcome all the participants of the International Conference on Enzymology at Rome, Italy. Enzymology is a very interdisciplinary field and this meeting indeed is most inclusive. Consequently, topics that will be addressed range from basic science to clinical issues, and from organic chemistry to biology. I regret I cannot make it this time due to previous commitments, but am sure you will all have a most interesting time at talks, discussions, poster presentations, and informal interaction with the many experts that will attend. Young and new scientist in particular should take advantage of this great opportunity to learn and be exposed to edge cutting research in the broad field of Enzymology. While in Rome, I also hope you will be able to enjoy the venue, this great and historic city, and the famous Italian hospitality.

Very best wishes

Amnon Kohen, D.Sc.
Professor of Chemistry
and Molecular and Cellular Biology
Director of the Biotechnology Training Program

Metabolomics Congress 2016

The 5th International Conference and Exhibition on Metabolomics, Metabolomics Congress 2016 was held in Osaka, Japan, during May 16 - 18, 2016.

Metabolomics Congress 2016 has welcomed the new era of Metabolomics; a futuristic arena for treatment of diseases, clasping a promising tomorrow. The highly exalted conference hosted by Conference Series LLC was marked with the attendance of young and brilliant researchers, business delegates and talented student communities representing more than 20 countries around the world. The conference has tried grounding every aspect related to Metabolomics and Cancer, covering all the possible research areas and crux. 

The conference aimed a parallel rail with theme “Fifty Shades of Metabolomics and Methodological Development”. The meeting engrossed a vicinity of cognizant discussions on novel subjects like Metabolomics and Cancer Research, Analytical Techniques in Metabolomics, Applications of Separation Sciences in Metabolomics, Frontiers of Metabolomics Research, Systems biology and Computational Biology, Bioinformatics and Advancements, Clinical Metabolomics and Lipidomics, to mention a few. The three days event implanted a firm relation of upcoming strategies in the field of Metabolomics with the scientific community. The conceptual and applicable knowledge shared, will also foster organizational collaborations to nurture scientific accelerations.

We are thankful to all our speakers for encouraging and supporting us to conduct the conference and catapulting the same to pinnacle of success.

The Organizing Committee would like to thank the moderators Dr. Eugenia Trushina, Mayo Clinic, USA and Dr. Houkai Li, Shanghai University of Traditional Chinese Medicine, China for their contributions which resulted in smooth functioning of the conference.

A series of invited lectures by Honorable guests and members of the Keynote Forum marked the commencement of the event. Prominent scientists like Petras Dzeja from Mayo Clinic, USA; Horng-Mo Lee from Taipei Medical University, Taiwan; Eugenia Trushina from Mayo Clinic College of Medicine, USA; Jian Zhi Hu from Pacific Northwest National Laboratory, USA; Loeffler Jean Philippe Université de Strasbourg, France; Björn Riefke from Bayer Pharma AG, Germany; Sam F Y Li, from National University of Singapore, Singapore; Ashkan Emadi from University of Maryland School of Medicine, USA; Houkai Li from Shanghai University of Traditional Chinese Medicine, China; gave their fruitful contributions in the form of highly informative presentations and made the conference a top notch one.

Conference Series LLC is prerogative to thank the Organizing Committee Members, Keynote speakers, Chair and Co-chairs on transcribing the plenary sessions and workshops in a diversified and variegate manner to make this conference an enviable artefact.

Conference Series LLC offers its heartfelt appreciation to our sponsor “Denator. Sweden”. We also express our sincere thanks to all the media partners for the promotion of our event to glory.

The supporting Sponsor who continuously shows confidence in our conferences were Denator.

The best poster presentations were awarded by Dr. Björn Riefke Bayer Pharma AG, Germany to:

Fatin Najwa, Universiti Putra Malaysia, Malaysia

Mei-Chen Lo, Taipei Medical University, Taiwan

Yoriko Heianza, Tulane University, USA

Conference Series LLC, on behalf of the conference, congratulates the Best poster awardees for their outstanding performance in the field of Metabolomics and appreciates all the participants who put their efforts in poster presentations and sincerely wishes them success in future endeavors.

Conference Series LLC 5th International Conference and Exhibition on Metabolomics would not have reached the pinnacle if not with the support of international, multi-professional steering committee and coordination of the Journal of Metabolomics: Open Access, Journal of Computer Science and Systems Biology; hence, we express our deep sense of gratitude.


Past Reports  Gallery  

Proteomics 2015

OMICS International takes a great pride in announcing the “5th International Conference on Proteomics & Bioinformatics” (Proteomics-2015) which was held in Valencia, Spain, during 01-03 September, 2015.

Proteomics-2015 witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various newfangled topics related to the field of proteomics and bioinformatics. The extremely illustrious conference hosted by OMICS International was marked with the attendance of young and brilliant researchers, business delegates and talented student communities representing more than 25 countries around the world.

The conference aimed a parallel rail with theme “Emerging trends with new innovations in proteomics and bioinformatics”. The meeting engrossed a vicinity of cognizant discussions on novel subjects like Proteomics from Discovery to Function, Mass Spectrometry in Proteome Research, Molecular Modeling & Drug Design, Recent advancements in Proteomics & Bioinformatics, to mention a few. The three days event implanted a firm relation of upcoming strategies in the field of Proteomics, Bioinformatics and Mass Spectrometry Technology with the scientific community. The conceptual and applicable knowledge shared, will also foster organizational collaborations to nurture scientific accelerations.

The Organizing Committee would like to thank the moderators Dr. Peter Nilsson, KTH-Royal Institute of Technology, Sweden, Dr. Alex Bayes, Biomedical Research Institute Sant Pau, Spain and Dr. Tiziana Bonaldi, European Institute of Oncology, Italy for their contributions which resulted in smooth functioning of the conference.

The conference was embarked with an opening ceremony followed by a series of lectures delivered by both Honorable Guests and members of the Keynote forum. The highlights of the conference were the keynote forum by prominent scientists, Peter Nilsson, KTH-Royal Institute of Technology, Sweden; Ida Pucci Minafra, University of Palermo, Italy; Magnus S Magnusson, University of Iceland, Iceland; Laszlo Takacs, Biosystems International, Hungary; gave their fruitful contributions in the form of highly informative presentations and made the conference a top notch one.

OMICS International is prerogative to thank the Organizing Committee Members, Keynote speakers, Chair and Co-chairs on transcribing the plenary sessions and workshops in a diversified and variegate manner to make this conference an enviable artifact.

OMICS International offers its heartfelt appreciation to the exhibitor Arrayjet, collaborator Bioval who supported the conference in every aspect for the awe-inspiring exhibition at the venue. We also express our sincere thanks to all the media partners for the promotion of our event to glory.

OMICS International congratulates the best poster award winner Dr. Marwa Eltoweissy, University Medicine of Gottingen, Germany and Brenden Van Wyk, University of Saskatchewan, Canada. We would also like to thank Dr. Patricia Sampaio Tavares Veras, Gonçalo Moniz Research Center- FIOCRUZ, Brazil who was our poster evaluator for her support.

We once again thank all the participants for their wonderful contribution towards the event which helped us for successful accomplishment of this event.

OMICS 5th International Conference on Proteomics & Bioinformatics would not have been successful if it has not been supported by international, multi-professional steering committee and coordination of the Journal of Proteomics & Bioinformatics, Journal of Pharmacogenomics & Pharmacoproteomics & Journal of Data Mining in Genomics & Proteomics.

 

After the successful completion of five consecutive conferences we are overwhelmed to announce our next upcoming conferences which are going to be held in Europe and USA are “7th International Conference and Expo on Proteomics” which is going to be held during October 24-26, 2016 in Rome, Italy, “6th International Conference & Expo on Proteomics” which is going to be held during March 29-31, 2016 Atlanta, USA, “6th International Conference on Bioinformatics” which is going to be held during August 22-23, 2016 Philadelphia, USA, and “7th International Conference on Bioinformatics” which is going to be held during October 24-25, 2016 Rome, Italy.


Past Reports  Gallery  

Protein Engineering 2015

Conference Series LLC takes a great pride in announcing the “International Conference on Protein Engineering” (Protein Engineering 2015) which was held in Chicago, USA during 26-28 October, 2015.

Protein Engineering 2015 witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various newfangled topics related to the field of proteomics and bioinformatics. The extremely illustrious conference hosted by Conferenceseries LLC was marked with the attendance of young and brilliant researchers, business delegates and talented student communities representing more than 25 countries around the world.

The conference aimed a parallel rail with theme “Current Trends and Challenges of Protein Dynamics”. The meeting engrossed a vicinity of cognizant discussions on novel subjects like Protein Engineering from Enzyme Engineering, Applications of Proteins, Structure and Function of Proteins, Pharmacogenomics and Pharmacoproteomics, to mention a few. The three days event implanted a firm relation of upcoming strategies in the field of Protein Engineering with the scientific community. The conceptual and applicable knowledge shared, will also foster organizational collaborations to nurture scientific accelerations.

The Organizing Committee would like to thank the moderators Somnath Mukherjee, University of Chicago, USA, Ryan Walsh, INRS–Institut Armand-Frappier Research Centre, Canada for their contributions which resulted in smooth functioning of the conference.

The conference was embarked with an opening ceremony followed by a series of lectures delivered by both Honorable Guests and members of the Keynote forum. The highlights of the conference were the keynote forum by prominent scientists, R Stephen Berry, The University of Chicago, USA; Ram Samudrala, State University of New York, USA; David Mead, Lucigen Corporation, USA; Karl Freed, University of Chicago, USA and Victor Tsetlin, Russian Academy of Sciences, Russia gave their fruitful contributions in the form of highly informative presentations and made the conference a top notch one.

Conference Series LLC is prerogative to thank the Organizing Committee Members, Keynote speakers, Chair and Co-chairs on transcribing the plenary sessions and workshops in a diversified and variegate manner to make this conference an enviable artifact.

Conference Series LLC express our sincere thanks to all the media partners for the promotion of our event to glory.

We once again thank all the participants for their wonderful contribution towards the event which helped us for successful accomplishment of this event.

Protein Engineering would not have been successful if it has not been supported by international, multi-professional steering committee and coordination of the Journal of Proteomics & Bioinformatics, Journal of Pharmacogenomics & Pharmacoproteomics & Journal of Data Mining in Genomics & Proteomics.

After the successful completion of five consecutive conferences we are overwhelmed to announce our “2nd International Conference on Genetic and Protein Engineering” which is going to be held during November 14-16, 2016 in Atlanta, USA.


Past Reports  Gallery  

Transcriptomics 2015

International Conference on Transcriptomics was held during July 27-29, 2015 at Hyatt Regency – Orlando International Airport, USA. The conference was marked with the attendance of Editorial Board Members of supported OMICS Group Journals, Scientists, young and brilliant researchers, business delegates and talented student communities representing more than 25 countries, who made this conference fruitful and productive.

This conference was based on the theme “Transcriptome Analysis: Unveiling the layers of Expressions” which included the following scientific tracks: 

·         Transcriptome analysis and Gene Expression-An Overview

·         RNA Editing and RNA Interference: Interplay

·         Next Generation Sequencing (NGS) Technologies

·         Disease Interrogation and Applications of RNA-Seq

·         Exploring the complexity of the Transcriptome

·         Refining expression analysis

·         Epigenetics

·         Functional Impact of Non-Coding RNA (ncRNA)

·         Cancer Genomics: Integrative and Computational Approaches

·         Expression Profiling

·         Clinical Applications and Related Disorders

·         Transcriptional Regulation and Transcriptional attenuation

·         Genomics, Proteomics and Bioinformatics

·         Transcriptomics and Proteomics of Microorganisms

·         Transcriptomics and Proteomics of Plants

·         Transcriptome technologies market

·         New Horizons to the Transcriptome

Transcriptomics-2015 was moderated by Dr. Andrey S. Krasilnikov (Penn State University, USA) on Day-1, Dr. Yingwei Mao (Pennsylvania State University, USA) on Day-2 and Dr. Vishwanath Sollapura (Agriculture and Agri-Food, Canada) on Day-3

 

We are thankful to our below Honourable guests for their generous support and suggestions.

 

Dr. Glen M Borchert – University of South Alabama, USA

Dr. William McCombie – Cold Spring Harbor Laboratory, USA

Dr. Momiao Xiong – University of Texas, United States

Dr. Max H Garzon – The University of Memphis, USA

The conference proceedings were carried out through various Scientific-sessions and plenary lectures, of which the following topics were highlighted as Keynote-presentations:

Fully mining RNA-Seqdata for noncoding RNA analyses: Glen M Borchert,University of South Alabama, USA

The impact of very long sequencing reads on our view of genomes and transcriptomes: William McCombie, Cold Spring Harbor Laboratory, USA

 

Various sessions were chaired and co-chaired by:

Momiao Xiong, University of Texas, USA

Yongming Sang, Kansas State University, USA

Andrey S Krasilnikov, Penn State University, USA

Yan Li, The Fourth Military Medical University, China

Harry Jarrett, University of Texas, USA

Ding-Gan Liu, Chinese Academy of Sciences, China

Max H Garzon, The University of Memphis, USA

Yingwei Mao, Pennsylvania State University, USA

Claire Lemaire, National Center for Scientific Research, France

Ilana Kolodkin, Weizmann Institute of Science, Israel

Sang Ming WANG, University of Nebraska Medical Center, USA

Punit Kaur, Morehouse School of Medicine, USA

Patrick Xuechun Zhao, Samuel Roberts Noble Foundation, USA

Zsolt Ponya, Kaposvar University, Hungary.

 

OMICS Group has taken the privilege of felicitating Transcriptomics-2015 Organizing Committee, Editorial Board Members and Keynote Speakers who supported for the success of this event.

The esteemed guests, Keynote speakers, well-known researchers and delegates shared their innovative research and vast experience through their fabulous presentations at the podium of grand Transcriptomics-2015. We are glad to inform that all accepted abstracts for the conference have been published in OMICS Group Journal of Transcriptomics: Open Access, as a special issue.

We are also obliged to various delegate experts, company representatives and other eminent personalities who supported the conference by facilitating active discussion forums. We sincerely thank the Organizing Committee Members for their gracious presence, support, and assistance. With the unique feedback from the conference, OMICS Group would like to announce the commencement of the "2nd International Conference on Transcriptomics" to be held during September 12-14, 2016 at Philadelphia, Pennsylvania, USA.


Past Reports  Gallery  

Click here to submit abstract to any of the above topics

sponsor

Want to Differentiate your company from your competitors and broaden your competitive edge?

Use our global platform of 3000+ Global Events

  • 25 Million+ Visitors to our Global website (conferenceseries.com)
  • 20000+ Unique Visitors per conference
  • 60000+ Page views per conference

For customized sponsorship opportunities at our conferences, or to place an ad on our websites, contact at sponsors@conferenceseries.com or call at: +1-650-268-9744

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date March 20-21, 2017
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity
Poster Opportunity Available

Media Partners

Conferenceseries Destinations